• Join Our Team
  • Contact Us
McDermott + Bull - Executive Search + Interim Leaders
  • INDUSTRIES
    • Aviation, Aerospace, + Defense
    • Consumer Brands
    • Education, Non-Profit, + Public Entities
    • Essential Services
    • Financial Services
    • Healthcare + Life Sciences
    • Industrial, Manufacturing, + Distribution
    • Private Equity
    • Real Estate
    • Technology
  • SERVICES
    • Executive Search
    • Interim Leaders
    • Performance Coaching
  • ABOUT M+B
    • Our Team
    • Diversity
  • INSIGHTS
Select Page
  • Contact Us
  • Services
    • Executive Search
    • Interim Leaders
    • Performance Coaching
  • Industries
    • Aviation, Aerospace, + Defense
    • Consumer Brands
    • Education, Non-Profit, + Public Entities
    • Essential Services
    • Financial Services
    • Healthcare + Life Sciences
    • Industrial, Manufacturing, + Distribution
    • Private Equity
    • Real Estate
    • Technology
  • About M+B
    • Our Team
    • Diversity
  • Insights
  • Join Us
A Conversation on Revolutionizing Vascular Care + Challenging the Medical Field

A Conversation on Revolutionizing Vascular Care + Challenging the Medical Field

by McDermott + Bull | Mar 13, 2023 | Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article

A CONVERSATION WITH RENOWNED VASCULAR SURGEON, DR. FRANK J. VEITH As one of America’s most celebrated surgeons, Dr. Frank Veith’s career was anything but conventional – he’s worked undercover for the CIA, attempted to make Vascular Surgery an independent specialty,...
The Top CEO Traits For Leading A Start-Up In Life Sciences

The Top CEO Traits For Leading A Start-Up In Life Sciences

by McDermott + Bull | Feb 16, 2023 | Article, Healthcare + Life Sciences Article, Jake Vander Zanden, Jake Vander Zanden Article

In 2022, we saw a significant increase in the number of deals by private equity and venture capital firms within the life sciences, medical, and healthcare sectors. This all points toward positive growth, but the biggest challenge PE and VC firms face is seeing a...
MedTech + Life Sciences 2023 State of the Market for Executive Hiring

MedTech + Life Sciences 2023 State of the Market for Executive Hiring

by McDermott + Bull | Feb 1, 2023 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article

MEDTECH + LIFE SCIENCES OUTLOOK IN 2023 2022 was an interesting year, to say the least. It was the tale of two markets. After the extremely volatile years of 2020 and 2021, no one could have predicted the sheer amount of momentum that lay ahead in 2022. The economy...
2022 Top Mergers + Acquisitions In MedTech + Life Sciences

2022 Top Mergers + Acquisitions In MedTech + Life Sciences

by McDermott + Bull | Nov 24, 2022 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article

Heading into 2022, many expected the rapid continuation of strong initial public offerings (IPOs) and merger + acquisition (M+A) activity. Wow, that was off. The underestimated implications of supply chain issues, geopolitical concerns, and Federal Trade Commission...
2023 Forecast of Executive Hiring Trends in Life Sciences

2023 Forecast of Executive Hiring Trends in Life Sciences

by McDermott + Bull | Nov 22, 2022 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Jake Vander Zanden, Jake Vander Zanden Article

2022 has been an interesting year for life sciences and executive search. We have finally been able to attend in-person conferences and events without the looming fear of the COVID-19 pandemic hanging over our heads. In October, Jessica Combs and I attended the...
Article: Private Equity Trends in Healthcare

Article: Private Equity Trends in Healthcare

by McDermott + Bull | Jul 25, 2022 | Article, Garrett Lipus, Garrett Lipus Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Lipus

RECENT ACTIVITY IN THE HEALTHCARE INDUSTRY  Private equity healthcare services’ activity levels reached record highs in 2021 and have remained robust throughout the first half of 2022. Of the 105 healthcare services comps, the median enterprise value or EBITDA...
« Older Entries
Next Entries »

Recent Posts

  • McDermott + Bull Announces Strategic Expansion of Essential Services Practice
  • Aligning Growth with Financial Precision: How an Interim CFO Supported Strategic Planning for a PE-Backed Consumer Packaged Goods Manufacturer
  • Driving Deal Readiness: How an Interim CFO Enabled a Successful Sale for a Retail and Distribution Company
  • McDermott + Bull Places Chief of Development and Communications at Care For the Homeless
  • McDermott + Bull Places Controller at LA Family Housing

Categories

Copyright 2020 McDermott + Bull, Inc. All rights reserved.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo